HQL Projected Dividend Yield

Sh Ben Int/abrdn Life Sciences Investors ( NYSE : HQL )

Tekla Life Sciences Investors is a non-diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in United States and foreign companies in the life sciences industry (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management. The Fund invests primarily in securities of public and private companies.

10 YEAR PERFORMANCE RESULTS